Profile for Clovis Oncology Inc. (CLVS)

$ 5.41   -0.30 (-5.25%) Volume: 3.1m 4:00 PM EDT 13-Sep-2019
After Hours:  $ 5.41 0.00 (0.00%) Volume: 58.27k 6:53 PM EDT 13-Sep-2019
Business Description:
Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.
Address: 5500 Flatiron Parkway, Suite 100, Boulder, CO, USA, 80301
Telephone: +1 303 625-5000 Website:
Facsimile: +1 303 245-0360 Email: [email protected]
CEO: Patrick J. Mahaffy
Employees: 468 Market Cap: 295.69m
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion with Explanation
Indices: Biotechnology, DJ US Biotechnology, Morningstar US Market Factor Tilt PR USD, Morningstar US Market Factor Tilt TR USD
Industry Classifications
Sector: Healthcare CIK: 1466301
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)